CONGENITAL CHYLOTHORAX TREATED WITH OCTREOTIDE, CASE REPORT

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

HOSSEINI M.B.; ASLAN ABADI S.; SAFARI A.; MIRZAIE S.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Feyz Medical Sciences Journal Year:2014 | Volume:18 | Issue:3 Page(s): 281-285

Download Full-Text

Persian Verion

View:

1,034

Download:

Cites:

Information Journal Paper

Title

CONGENITAL CHYLOTHORAX TREATED WITH OCTREOTIDE, CASE REPORT

Author(s)

HOSSEINI M.B. | ASLAN ABADI S. | SAFARI A. | MIRZAIE S. | Issue Writer Certificate

Keywords

CONGENITAL CHYLOTHORAXQ2

PLEURAL EFFUSIONQ3

RESPIRATORY DISTRESS SYNDROMEQ2

Abstract

Background: CONGENITAL CHYLOTHORAX is the accumulation of lymphatic fluid within the pleural space. Cases unresponsive to conservative management usually require surgery. Although octreotide has been used successfully to treat chylothorax, the exact mechanism of its action is uncertain and it is believed to reduce the lymphatic drainage through a direct action on splanchnic lymph flow.Case Report: We report two cases of CONGENITAL CHYLOTHORAX who did not respond to supportive therapy (nutritional support and drainage) and where surgery service was avoided with the compassionate trial of octreotide. The first case was a 50-day-old infant with Noonan syndrome phenotype and another was an 18-day-old neonate with idiopathic CONGENITAL CHYLOTHORAX. Treatment was associated with prompt respiratory improvement soon after starting the octerotide treatment and in the first and second cases the clinical symptoms resolved completely in 12 and 10 days after the onset of the treatment, respectively. Octreotide infusion was started at an initial dosage of 3 mg/kg/hour and increased daily by 1 mg/kg/hour to maximum 8 mg/kg/hour. The patients were well 2 months after the treatment.Conclusion: Octreotide infusion appears to have a good safety profile in newborns and remains a promising alternative to surgery for recalcitrant cases of chylothorax. Further studies are required to ascertain its true value in CONGENITAL CHYLOTHORAX.

Cites

No record.

References

No record.

Cite

APA: Copy

HOSSEINI, M.B., ASLAN ABADI, S., SAFARI, A., & MIRZAIE, S.. (2014). CONGENITAL CHYLOTHORAX TREATED WITH OCTREOTIDE, CASE REPORT. FEYZ, 18(3), 281-285. SID. https://sid.ir/paper/40823/en

Vancouver: Copy

HOSSEINI M.B., ASLAN ABADI S., SAFARI A., MIRZAIE S.. CONGENITAL CHYLOTHORAX TREATED WITH OCTREOTIDE, CASE REPORT. FEYZ[Internet]. 2014;18(3):281-285. Available from: https://sid.ir/paper/40823/en

IEEE: Copy

M.B. HOSSEINI, S. ASLAN ABADI, A. SAFARI, and S. MIRZAIE, “CONGENITAL CHYLOTHORAX TREATED WITH OCTREOTIDE, CASE REPORT,” FEYZ, vol. 18, no. 3, pp. 281–285, 2014, [Online]. Available: https://sid.ir/paper/40823/en

Related Journal Papers